IMMX vs MAA · $640.7M cap vs P/E 31, rev $2.21B
Immix Biopharma Inc (IMMX) versus Mid-America Apartment Communities Inc (MAA) — a side-by-side from cached financials, not a winner call.
Immix Biopharma Inc (IMMX) is a biotechnology company listed on US.
Mid-America Apartment Communities Inc (MAA) is a reit - residential company listed on US.
IMMX does not have a complete income-statement cache yet.
Latest reported MAA revenue for 2025-12-31 was $2.21B. Net income was $446.9M. Revenue was up 0.8% from 2024-12-31 to 2025-12-31. MAA currently screens at market cap $18.07B and trailing P/E 31.2.
IMMX currently screens at market cap $640.7M. MAA currently screens at market cap $18.07B and trailing P/E 31.2.
Not investment advice. Open the IMMX and MAA stock pages for the full models.
Not investment advice.